BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 29587747)

  • 1. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Calpena AC; Folch J; Camins A; García ML
    Nanomedicine; 2017 Apr; 13(3):1171-1182. PubMed ID: 27986603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
    Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
    J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro.
    Baysal I; Ucar G; Gultekinoglu M; Ulubayram K; Yabanoglu-Ciftci S
    J Neural Transm (Vienna); 2017 Jan; 124(1):33-45. PubMed ID: 26911385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies.
    Silva-Abreu M; Calpena AC; Andrés-Benito P; Aso E; Romero IA; Roig-Carles D; Gromnicova R; Espina M; Ferrer I; García ML; Male D
    Int J Nanomedicine; 2018; 13():5577-5590. PubMed ID: 30271148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease.
    Fan S; Zheng Y; Liu X; Fang W; Chen X; Liao W; Jing X; Lei M; Tao E; Ma Q; Zhang X; Guo R; Liu J
    Drug Deliv; 2018 Nov; 25(1):1091-1102. PubMed ID: 30107760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma.
    Sánchez-López E; Egea MA; Davis BM; Guo L; Espina M; Silva AM; Calpena AC; Souto EMB; Ravindran N; Ettcheto M; Camins A; García ML; Cordeiro MF
    Small; 2018 Jan; 14(2):. PubMed ID: 29154484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
    Huo X; Zhang Y; Jin X; Li Y; Zhang L
    J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ
    Amin FU; Shah SA; Badshah H; Khan M; Kim MO
    J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.
    Ettcheto M; Sánchez-López E; Gómez-Mínguez Y; Cabrera H; Busquets O; Beas-Zarate C; García ML; Carro E; Casadesus G; Auladell C; Vázquez Carrera M; Folch J; Camins A
    Mol Neurobiol; 2018 Sep; 55(9):7327-7339. PubMed ID: 29404958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms.
    Du Y; Qu J; Zhang W; Bai M; Zhou Q; Zhang Z; Li Z; Miao J
    Neuropharmacology; 2016 Sep; 108():1-13. PubMed ID: 27067919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study.
    Gajbhiye KR; Gajbhiye V; Siddiqui IA; Pilla S; Soni V
    Sci Rep; 2017 Sep; 7(1):11086. PubMed ID: 28894228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.
    Guan Q; Sun S; Li X; Lv S; Xu T; Sun J; Feng W; Zhang L; Li Y
    J Mater Sci Mater Med; 2016 Feb; 27(2):24. PubMed ID: 26704541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
    Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer's Disease.
    Xu R; Wang J; Xu J; Song X; Huang H; Feng Y; Fu C
    Int J Nanomedicine; 2020; 15():1149-1160. PubMed ID: 32110013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
    Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
    Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice.
    Gothwal A; Kumar H; Nakhate KT; Ajazuddin ; Dutta A; Borah A; Gupta U
    Bioconjug Chem; 2019 Oct; 30(10):2573-2583. PubMed ID: 31553175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
    Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides.
    Nunes R; Araújo F; Barreiros L; Bártolo I; Segundo MA; Taveira N; Sarmento B; das Neves J
    ACS Appl Mater Interfaces; 2018 Oct; 10(41):34942-34953. PubMed ID: 30234288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.